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INTRODUCTION
Rokumi-gan (TJ-87) is a plant prescription for as-
thenia of kidney in traditional East-Asian medicine
(1). It consists of six plants (Rehmannia Root, Cor-
nus Fruit, Dioscorea Rhizome, Alisma Rhizome, Hoe-
len and Moutan Bark) containing many low and high
molecular compounds, such as terpenoids, flavonoids,
amino acids and proteins (1-3). Rokumi-gan is one
of the most common body enrichment drugs and
is widely used for pollakisuria, dysurea and edema,
which resulted from nephrosis and chronic nephri-
tis (2-4). We also reported that a long-term admini-
stration of Rokumi-gan increased serum total pro-
tein concentration and improved edema in patients
with renal failure (5). In contrast, it is well-known
that supplementation of amino acids has beneficial
effects on plasma amino acids and protein levels in
chronic renal failure, leading to the improvement of
dysuria and edema (6-8). Based on these findings,
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we hypothesized that Rokumi-gan may have sev-
eral amino acids and/or proteins for its beneficial
effects on renal diseases.
In this study, we examined amounts of amino ac-
ids in Rokumi-gan and its effect on serum amino acid
concentration in 6 healthy volunteers to elucidate
the function as a beneficial amino acid supplier. We
found that Rokumi-gan contained high amounts of
various amino acids, especially arginine, glutamate
and aspartate. A single administration of Rokumi-
gan effectively increased serum concentration of
alanine, arginine, glutamate, glycine and serine in
human beings, compared with treatment with an
amino acid mixture or lactose. Rokumi-gan has bene-
ficial amino acids/proteins, at least in part, contrib-
uting to keep levels of serum amino acids constant for
several hours.
MATERIALS AND METHODS
Subjects
Six healthy men (age 35.5 ± 4.8 years, height
168 ± 3.5 cm, body weight 67.7 ± 4.8 kg, body mass
index 23.9 ± 0.9 kg/m2) participated in the experi-
ment after giving informed consent to the experi-
mental protocol, which had been approved by the
ethical committee of The Komatsushima Hospital.
All subjects had physical examinations performed
by a physician before participating in this study.
Administration of Rokumi-gan, amino acid mixture
and lactose
This study was designed as a lactose-amino acid
mixture-Rokumi-gan randomized crossover trial. The
following treatments were administered : lactose treat-
ment, 5 g of lactose ; amino acid mixture treatment ;
5 tablets of amino GET (Asahi, Osaka, Japan) ; pre-
scription treatment, 10 g of commercially prepared
Rokumi-gan (TJ-87) purchased from Tsumura Phar-
maceutical Co. (Tokyo, Japan). Since commercially
prepared Rokumi-gan contained 5 g of lactose as an
expicient, we used 5 g of lactose as control. Five
tablets of amino Get contains almost similar amounts
of Ala, Arg, Asp, Glu, Gly, Phe and Ser with those in
10 g of commercially prepared Rokumi-gan (Ala,
25.2 ; Arg, 49.8 ; Asp, 48.6 ; Cys, 3.2 ; Glu 99.6, Gly
19.0 ; Gln, 59 His 7.8 ; Ile, 77.6 ; Leu, 104 ; Lys
26.0 ; Met, 5.6, Phe, 13.8 ; Pro, 15.2, Ser, 18.4 ;
Thr, 16.8 ; Trp, 4.2 ; Tyr, 9.6 ; Val, 71.2 mg/5
tablets), although Rokumi-gan did not contain cys-
teine, methionine, proline, threonine and tyrosine.
A washout period of three month was maintained
between the treatments. The subjects entered hos-
pital one day before the each study day. From 21 : 00
on the day before each study no meal and bever-
age were allowed except for a free intake of water
until 6 hrs after administration of a lactose, amino
acid mixture or Rokumi-gan. During the same pe-
riod, the subjects were allowed to be free, except
for smoking and hard working. On the study day,
a lactose, amino acid mixture or Rokumi-gan was
administered to all subjects with 180 ml of water at
9 : 00. Blood samples were taken before or at 1, 2,
4, and 6 hr after the administration.
Determination of serum amino acid concentration
The blood samples were centrifuged for 10 min
at 3,500 rpm to separate cells from serum, which
was immediately frozen and stored at -80℃ until
analysis. To measure serum amino acid concentra-
tion, the serum was subjected to amino acid ana-
lyzer, as described previously (9). Briefly, these
samples were deproteinized with 5% sulphosalicylic
acid and subjected to an automatic Hitachi L-8500
A amino acid analyzer (Hitachi, Tokyo, Japan) using
cation exchange column with sulfonate group (2622-
SC, 4.6 × 60 mm) and fluorescence detection. All
samples were analyzed in duplicate.
Measurement of amino acid constitution in Rokumi-
gan
We determined the amino acid constitution in two
kinds of Rokumi-gan : commercially prepared drugs
with three different lots (No. I, II and III) and self-
decocted extract from the six plants. The plants
were purchased from Tsumura Pharmaceutical Co.
The production places of the original plants be-
tween commercially prepared (Lot No. I) and self-
decocted drugs were same. Daily dose (7.5 g of
dry powder) of the commercially prepared drug
was made from 5 g of Rehmannia Root, 3 g of Cor-
nus Fruit, 3 g of Dioscorea Rhizome, 3 g of Alisma
Rhizome, 3 g of Hoelen and 3 g of Moutan Bark.
Therefore, we prepared the self-decocted extract from
the same amounts of the six plants : the plants were
incubated in 660 ml of water at 60℃ for 1 hr with a
decoction apparatus (Uchida, Tokyo Japan). Ali-
quots of both samples were hydrolyzed with 6 N
HCl at 121℃ for 16 hr. Following digestion, the
samples were titrated to pH 4-5 with 5 M KOH and
centrifuged to remove precipitate and were sub-
jected to amino acid analysis as described above.
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Statistical analysis
All data were expressed as mean ± SEM, n = 3
or 6. One-way ANOVA followed by Dunnett’s test
was used to determine the different amounts of
amino acids between self-decocted and commercially-
prepared Rokumi-gan, or to evaluate the signifi-
cant effects of Rokumi-gan, amino acid mixture and
lactose on serum amino acid concentration, com-
pared with that before treatment with each agent.
We also applied the results to the modified Bonfer-
roni correction, Holm procedure, for multiple test-
ing (10) to compare the distinct effects of Rokumi-
gan, amino acid mixture and lactose on serum amino
acid concentration at the indicated periods after the
treatment. These analyses were performed using
SPSS computer programs (SPSS Japan Inc., Tokyo).
RESULTS
Amino acid amounts in commercially prepared and
Rokumi-gan with three different lots
Commercially prepared Rokumi-gans with three
different lots contained similar kinds and amounts
of amino acids (Table 1). Especially, the Rokumi-gan
contained high amounts (more than 20 mg/10 g
Rokumi-gan) of arginine, aspartate and glutamate.
It had alanine, phenylalanine and serine at the mod-
erate levels (10-20 mg/10 g Rokumi-gan), and gly-
cine, histidine, isoleucine, leucine, lysine and valine
at the low levels (less than 10 mg/10 g Rokumi-gan).
Cysteine, methionine, proline, threonine and tryp-
tophan were hardly detected in the commercially
prepared Rokumi-gan. Interestingly, Rokumi-gan
without hydrolyzation contained few amounts of
amino acids, except for arginine (Table 1), indicat-
ing that almost of all amino acids were present as
peptides or proteins. Unexpectedly, Rokumi-gan con-
tained a high amount of free arginine.
Amino acid amounts in self-decocted Rokumi-gan
Self-decocted Rokumi-gan significantly contained
1.6-fold-higher amounts of total amino acids (Table
2). Amounts of glutamate, isoleucine and serine in
self-decocted Rokumi-gan were significantly higher
than those in commercially prepared drug, whereas
self-decocted Rokumi-gan contained lower amounts
Table 1. Amino acid contents in Rokumi-gan with or without hydrolyzation.
No-hydrolyzation (mg/10 g Rokumi-gan) Hydrolyzation (mg/10 g Rokumi-gan)
Fold
Lot I II III Average I II III Average
Ala 4.7 ± 0.5 7.1 ± 0.1 7.0 ±0.1 6.3 12.9 ± 1.4 16.8 ± 1.6 22.0 ± 3.5 17.2 2.7
Arg 45.8 ± 2.2 45.2 ± 0.7 42.8 ± 0.4 44.3 59.1 ± 1.7 58.8 ± 1.4 58.6 ± 1.1 58.8 1.3
Asp 2.8 ± 0.2 3.0 ± 0.1 2.7 ± 0.1 2.8 41.9 ± 4.0 41.0 ± 4.7 36.9 ± 6.7 39.9 14.3
Glu 1.2 ± 0.1 1.6 ± 0.1 1.5 ± 0.1 1.4 55.5 ± 3.1 63.3 ± 3.0 60.5 ± 5.0 59.8 42.7
Gly 0.7 ± 0.1 1.1 ± 0.1 1.1 ± 0.1 1.0 13.5 ± 2.6 7.7 ± 0.1 8.4 ± 0.7 9.9 9.9
His 0 0 0 0 4.0 ± 0.4 3.6 ± 0.2 5.4 ± 1.0 4.3
Ile 1.0 ± 0.2 1.4 ± 0.2 1.2 ± 0.1 1.2 3.3 ± 0.5 3.8 ± 0.8 2.9 ± 0.2 3.3 2.8
Leu 1.2 ± 0.1 0.7 ± 0.1 1.1 ± 0.2 1.0 6.4 ± 0.5 8.3 ± 0.8 7.4 ± 1.0 7.4 7.4
Lys 1.6 ± 0.2 1.7 ± 0.1 1.7 ± 0.1 1.7 7.6 ± 0.1 8.4 ± 0.1 8.2 ± 0.1 8.1 4.8
Phe 8.2 ± 0.4 8.0 ± 0.8 9.0 ± 0.2 8.4 18.5 ± 0.5 17.9 ± 0.6 18.2 ± 0.4 18.2 2.2
Ser 5.3 ± 2.6 4.4 ± 0.1 4.5 ± 0.3 4.7 13.2 ± 0.6 16.2 ± 0.2 10.9 ± 2.3 13.4 2.9
Val 2.0 ± 0.1 1.9 ± 0.2 2.3 ± 0.1 2.1 5.8 ± 1.3 5.5 ± 0.2 4.2 ± 0.7 5.2 2.5
Total 74.5 76.1 74.9 74.9 231.7 251.3 243.6 245.4 3.3
We determined the amino acid constitution in commercially prepared Rokumi-gans with three different lots (No. I, II and III) before
or after hydrolyzation. Hydrolyzation and amino acid analysis were performed as described in Materials and Methods. Cys, Met,
Pro, Thr, Tyr, Asn, Gln and Trp were not detected in Rokumi-gan. However, Asn and Gln may be oxidized to Asp and Glu, respec-
tively, in hydrolyzed Rokumi-gan, since the sample was treated with 6 N HCl.
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of aspartate and phenylalanine than commercially
prepared drug. There was no difference in amounts
of other amino acids between self-decocted and com-
mercially prepared drugs.
Changes in serum amino acid concentration after a
single administration of Rokumi-gan
We measured serum amino acid concentrations
in 6 healthy volunteers before or after administration
of Rokumi-gan, an amino acid mixture or lactose.
The actual value and relative ratio to the value be-
fore administration of serum acid concentration were
shown in Table 3 and Fig. 1, respectively. In healthy
volunteers treated with lactose, the concentrations
of almost of all serum amino acids tested gradually
decreased in time-dependent manner. Unexpectedly,
treatment with an amino acid mixture containing
similar amounts to Rokumi-gan hardly changed se-
rum amounts of amino acids. Almost of all amino
acids, except for arginine, were sustained at the ba-
sal level or gradually decreased after the treatment.
In contrast, treatment with Rokumi-gan significantly
increased the levels of serum alanine, serine and
glycine which were contained in Rokumi-gan at the
moderate or low levels, compared with treatment
with an amino acid mixture. Rokumi-gan also in-
creased the levels of serum arginine and glutamate,
which were highly contained in Rokumi-gan. Al-
most of these amino acids showed peak values 1 or
2 hr after administration, whereas serum glutamate
level gradually increased until 6 hr after admini-
stration. The increase in serum arginine level after
treatment with Rokumi-gan was not statistically sig-
nificant, compared with that after treatment with
an amino acid mixture. This is consistent with the
finding that Rokumi-gan contained a high amount
of free arginine (Table 1). Rokumi-gan effectively
prevented time-dependent declines in the amounts
of serum histidine, isoleucine and leucine, which
were observed in volunteers treated with lactose or
an amino acid mixture. Serum aspartate was not de-
tected in all samples, although there was aspartate
at the high level in the powder.
Table 2. Amounts of amino acids in self-decocted Rokumi-gan.
Self-decocted1
(mg/10 g equivalent to
commercially prepared)
Ratio to commercially
prepared1
Ala 21.2 ± 0.4＊ 1.2
Arg 66.3 ± 0.8＊ 1.1
Asp 47.9 ± 0.4＊ 0.5
Glu 107.0 ± 0.4＊ 1.8
Gly 8.7 ± 0.4 0.9
His 3.6 ± 0.4 0.8
Ile 6.3 ± 0.4 1.9
Leu 7.9 ± 0.4 1.1
Lys 7.2 ± 0.4 0.9
Phe 9.1 ± 0.8 0.5
Ser 21.6 ± 0.4＊ 2.7
Val 9.6 ± 0.4 1.8
Cys, Met, Pro, Thr, Tyr not detected
Asn2, Gln2, Trp not determined
Total 316.4 1.6
1We hydrolyzed self-decocted Rokumi-gan with 6N HCl and determined the amounts of amino acids, as described in Materials and
Methods. The ratio of amino acid contents of self-decocted to those of commercially prepared Rokumi-gan (See Table 1) was calcu-
lated.
2Asn and Gln were oxidized to Asp and Glu, respectively, since the sample was hydrolyzed with 6 N HCl.
Data are shown as mean ± SEM (n = 3). ＊Significantly different, compared with the value in commercially-prepared Rokumi-gan (P < 0.05).
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Table 3. Changes in serum amino acid concentration after single administration of Rokumi-gan, amino acid mixture and lactose.
Time after administration
0 hr (Before) 1 hr 2 hr 4 hr 6 hr
(nmol/ml of serum)
Ala Lactose : 389.6 ± 28.8 394.6 ± 31.5 382.6 ± 26.8 349.2 ± 25.8＊ 311.4 ± 20.9＊＊
Amino Acids : 335.7 ± 45.0 327.9 ± 39.0 310.6 ± 32.7 290.5 ± 24.2＊ 273.6 ± 24.2＊＊
Rokumi-gan : 256.3 ± 8.5 283.5 ± 11.4 293.4 ± 15.0＊ 262.5 ± 9.8 255.5 ± 14.9
Arg Lactose : 75.7 ± 8.5 72.1 ± 8.0 72.8 ± 9.3 70.3 ± 8.3 72.8 ± 7.7
Amino Acids : 81.5 ± 18.3 92.7 ± 13.0 81.1 ± 9.7 84.5 ± 10.9 81.0 ± 9.5
Rokumi-gan : 78.9 ± 7.7 84.3 ± 8.1 86.5 ± 7.2 81.4 ± 6.4 77.7 ± 5.9
Glu Lactose : 150.9 ± 18.6 152.3 ± 20.5 166.1 ± 18.1 162.5 ± 24.8 145.6 ± 19.8
Amino Acids : 129.9 ± 27.8 113.3 ± 18.3 106.6 ± 18.7＊ 101.7 ± 18.3＊＊ 103.2 ± 20.0＊
Rokumi-gan : 164.2 ± 16.9 179.8 ± 15.3 178.8 ± 21.3 176.4 ± 20.6 183.0 ± 20.0
Gly Lactose : 236.7 ± 17.0 235.3 ± 14.6 235.1 ± 18.8 224.7 ± 17.4 213.4 ± 18.4＊＊
Amino Acids : 252.7 ± 10.7 237.6 ± 13.6 233.0 ± 20.7 222.6 ± 18.8＊＊ 218.3 ± 18.7＊＊
Rokumi-gan : 256.3 ± 8.5 283.5 ± 11.4＊ 293.4 ± 15.0 262.5 ± 9.8 255.5 ± 14.9
His Lactose : 88.6 ± 2.4 87.8 ± 2.5 86.5 ± 0.9 90.6 ± 2.6 89.6 ± 1.9
Amino Acids : 89.2 ± 3.9 91.8 ± 4.2 87.2 ± 3.7 87.6 ± 2.4 85.3 ± 2.8
Rokumi-gan : 94.3 ± 2.1 100.3 ± 2.8 99.6 ± 4.8 99.8 ± 5.5 100.3 ± 3.7
Ile Lactose : 79.4 ± 4.0 72.7 ± 3.9＊ 69.5 ± 2.3＊＊ 69.3 ± 3.1＊＊ 71.2 ± 3.0＊＊
Amino Acids : 75.9 ± 3.0 77.6 ± 1.6 71.4 ± 2.0 64.9 ± 1.6＊＊ 63.1 ± 2.0＊＊
Rokumi-gan : 78.7 ± 4.9 77.4 ± 5.5 74.7 ± 4.2 75.1 ± 4.4 76.7 ± 3.6
Leu Lactose : 148.9 ± 6.6 140.3 ± 7.0 139.1 ± 5.2 142.8 ± 5.8 147.0 ± 6.5
Amino Acids : 157.9 ± 6.2 160.2 ± 5.7 152.4 ± 5.8 148.4 ± 5.0 146.6 ± 3.4＊
Rokumi-gan : 156.8 ± 8.7 158.3 ± 9.9 155.9 ± 9.9 160.3 ± 9.9 162.1 ± 7.5
Lys Lactose : 205.9 ± 5.2 206.5 ± 5.7 211.3 ± 8.0 221.6 ± 11.5 221.6 ± 8.1
Amino Acids : 224.5 ± 11.8 216.9 ± 10.3 209.5 ± 7.2 211.6 ± 7.1 206.6 ± 7.4
Rokumi-gan : 241.5 ± 14.8 237.5 ± 13.9 243.7 ± 17.7 242.8 ± 16.3 243.2 ± 10.8
Phe Lactose : 72.5 ± 1.8 70.1 ± 1.5 74.4 ± 2.0 73.4 ± 1.3 71.8 ± 1.2
Amino Acids : 63.3 ± 9.1 59.7 ± 4.1 55.9 ± 4.9 55.0 ± 4.6 51.8 ± 5.0
Rokumi-gan : 86.5 ± 4.0 84.8 ± 3.7 85.2 ± 7.1 82.0 ± 4.5 83.5 ± 4.3
Ser Lactose : 124.4 ± 4.8 126.7 ± 4.6 132.3 ± 6.9 126.2 ± 3.9 123.5 ± 4.3
Amino Acids : 141.5 ± 6.9 125.6 ± 9.6 118.4 ± 8.6＊ 121.1 ± 7.6 117.7 ± 7.7＊
Rokumi-gan : 135.5 ± 3.9 162.9 ± 9.1＊＊ 147.4 ± 8.1 143.2 ± 5.4 144.5 ± 2.9
Val Lactose : 263.0 ± 8.6 253.6 ± 9.0 252.2 ± 7.3 249.4 ± 7.9 249.3 ± 7.8
Amino Acids : 241.1 ± 9.6 245.4 ± 8.2 237.2 ± 8.8 233.3 ± 6.0 233.4 ± 6.0
Rokumi-gan : 263.5 ± 17.1 271.2 ± 17.0 267.2 ± 20.9 264.0 ± 19.3 265.4 ± 14.0
Asn, Cys, Gln, Met, Pro, Thr, Trp, Tyr = not determined, Asp = not detected
Rokumi-gan (10 g) and lactose (5 g) were administered to the same 6 healthy volunteers with 180 ml of water at 9 : 00. A washout
period of three month was maintained between both treatments. The volunteers were not allowed meal and beverage from 21 : 00
on the day before each study, except for a free intake of water. Blood samples were taken before or at 1, 2, 4, and 6 hr after the
administration. Then, serum was subjected to amino acid analysis. Data are shown as mean ± SEM (n = 6). ＊, ＊＊Significantly
different, compared with the value before treatment with each reagent (P < 0.05 and P < 0.01, respectively).
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Fig. 1. Relative changes in serum amino acid concentration after single administration of Rokumi-gan.
Rokumi-gan (10 g ; ), amino acid mixture treatment (5 tablets of amino GET ; ) and lactose (5 g ; ) were
administered to the same 6 healthy volunteers with 180 ml of water at 9 : 00. A washout period of three month was maintained
between both treatments. The volunteers were not allowed meal and beverage from 21 : 00 on the day before each study, except for
a free intake of water. Blood samples were taken before or at 1, 2, 4, and 6 hr after the administration. Then, serum was subjected to
amino acid analysis. Data are shown as the relative value to that before the treatment and mean ± SEM (n = 6). Values with differ-
ent superscripts are significant within the values at the indicated periods after treatment with each reagent (P < 0.05).
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DISCUSSION
This is the first report, to our knowledge, that
Rokumi-gan (TJ-87) contained relative high amounts
of various amino acids (4.9% in dried extracts exclud-
ing expicient), especially glutamate, arginine and
aspartate, and that administration of Rokumi-gan
could increase or sustain serum concentrations of
several amino acids in human subjects even 6 hrs
after treatment, compared with the treatment with
an amino acid mixture or lactose. Based on these
findings, Rokumi-gan may be a beneficial amino acid
supplier for keeping serum concentration constant.
Rokumi-gan contained glutamate and arginine at
the relative high levels. Recently, the evidence for
beneficial effects of these amino acids has been ac-
cumulated. For example, oral supplementation with
glutamate improved anorexia in rats (11). Dietary
L -arginine supplementation improved the glomeru-
lar filtration rate and renal blood flow after 24 hours
of unilateral ureteral obstruction in rats (7). Fur-
thermore, arginine improved erectile dysfunction
by increasing the amounts of endogenous nitric
oxide and stimulated secretion of growth hormone
(8, 12). Interestingly, Rokumi-gan is effective against
anorexia, asthenia of kidney, vigor and slow growth
of children (2, 13, 14), although the mechanism was
not proven. Such amino acids in Rokumi-gan may
contribute, at least in part, to its pharmaceutical ef-
fects.
Protein-restricted diets are more effective for re-
nal dysfunction, such as glomerular nephritis, neph-
rosis and renal failure, because they decrease uro-
genesis leading to the decrease in blood urea ni-
trogen (BUN) (15). Daily protein intake in patients
with renal failure was restricted up to 50% of that
(50 - 70 g/day) in normal persons. In contrast, sev-
eral amino acids themselves have beneficial effects
on renal function, and relative low amounts (at
most 1 g/day) of these amino acids are necessary
for their pharmaceutical effects (16). Therefore, it
is unlikely that amino acid supplementation with
Rokumi-gan (less than 250 mg/daily dose of Rokumi-
gan) causes the side-effects on renal function.
In subjects treated with a Rokumi-gan, serum con-
centrations of almost of all tested amino acids, ex-
cept for glutamate, showed the peak values within
2 hrs after treatment. However, an amino acid mix-
ture supplement containing similar amounts of amino
acids in Rokumi-gan may be immediately absorbed
and flushed out from blood within 1 hr after treat-
ment, in consistent with the previous report that se-
rum amino acids showed the peak value about 30
min after treatment with amino acid mixtures (17).
There is the following reason why treatment with
Rokumi-gan caused the distinct pattern of serum
amino acid levels from those with an amino acid
mixture. Amino acids in Rokumi-gan are present
as peptides or proteins, because hydrolyzation in-
creased amounts of amino acids in Rokumi-gan about
3 folds. Peptides or proteins in Rokumi-gan may
be gradually digested after treatment, and Rokumi-
gan could increase serum amino acid concentra-
tions for a long time. However, we can not exclude
another possibility that constituents in Rokumi-gan
disturb the absorption of amino acids in small in-
testine. Further examinations are necessary to elu-
cidate this possibility, since Rokumi-gan contains
many unidentified constituents.
Comparison of amino acid constituents between
pre-extracted drug and self-decocted extract revealed
that self-decocted extract contained 1.6-fold higher
amount of total amino acids than pre-extracted drug
did. Especially, amounts of glutamate, isoleucine
and serine in self-decocted extract were higher than
those in pre-extracted drug. These amino acids may
be destroyed during the preparation of pre-extracted
drug. Based on these findings, self-decocted extract
has bigger amounts of effectors than those in com-
mercially prepared drug.
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